NNNN
Anbio Biotechnology
Price Chart
No historical data available
Latest Quote
$7.30
-0.28 (-3.69%)
Current Price
| Previous Close | $7.58 |
| Open | $7.50 |
| Day High | $7.76 |
| Day Low | $7.08 |
| Volume | 279,190 |
Stock Information
| Shares Outstanding | 43.89M |
| Cash Equivalents | $11.90M |
| Revenue | $8.65M |
| Net Income | $6.40M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $320.41M |
| P/E Ratio | 48.67 |
| EPS (TTM) | $0.15 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Anbio Biotechnology
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
đ° Latest News
No news articles available at the moment. Check back later for updates on NNNN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,103,682 | $2,299,762 | $3,351,121 | $10,980,847 |
| Cost Of Revenue | $1,103,682 | $2,299,762 | $3,351,121 | $10,980,847 |
| Total Revenue | $8,646,844 | $8,185,146 | $6,711,990 | $23,544,652 |
| Operating Revenue | $8,646,844 | $8,185,146 | $6,711,990 | $23,544,652 |
| Expenses | ||||
| Total Expenses | $2,879,104 | $6,189,779 | $4,751,061 | $13,349,064 |
| Other Income Expense | $493,700 | $39,964 | $127,444 | $-218,657 |
| Other Non Operating Income Expenses | $138 | $19,495 | $8,025 | $43,562 |
| Net Non Operating Interest Income Expense | $142,023 | $337,511 | $165,336 | $34,246 |
| Operating Expense | $1,775,422 | $3,890,017 | $1,399,940 | $2,368,217 |
| Interest Expense | - | $0 | $0 | $7,999 |
| Interest Expense Non Operating | - | $0 | $0 | $7,999 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Net Interest Income | $142,023 | $337,511 | $165,336 | $34,246 |
| Interest Income | $142,023 | $337,511 | $165,336 | $42,245 |
| Normalized Income | $5,909,901 | $2,352,373 | $2,134,290 | $10,273,396 |
| Net Income From Continuing And Discontinued Operation | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Total Operating Income As Reported | $5,767,740 | $1,995,367 | $1,960,929 | $10,195,588 |
| Net Income Common Stockholders | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Net Income | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Net Income Including Noncontrolling Interests | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Net Income Continuous Operations | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Pretax Income | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Interest Income Non Operating | $142,023 | $337,511 | $165,336 | $42,245 |
| Operating Income | $5,767,740 | $1,995,367 | $1,960,929 | $10,195,588 |
| Gross Profit | $7,543,162 | $5,885,384 | $3,360,869 | $12,563,805 |
| Per Share | ||||
| Diluted EPS | - | $0.05 | $0.01 | $0.07 |
| Basic EPS | - | $0.05 | $0.02 | $0.07 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $5,274,178 | $1,974,898 | $1,853,569 | $10,287,647 |
| Total Unusual Items | $493,562 | $20,469 | $119,419 | $-262,219 |
| Total Unusual Items Excluding Goodwill | $493,562 | $20,469 | $119,419 | $-262,219 |
| EBITDA (Bullshit earnings) | $5,767,740 | $1,995,367 | $1,972,988 | $10,025,428 |
| EBIT | $5,767,740 | $1,995,367 | $1,960,929 | $10,019,176 |
| Diluted NI Availto Com Stockholders | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $493,562 | $20,469 | $119,419 | $-262,219 |
| Research And Development | $201,305 | $454,227 | $134,700 | $200,000 |
| Selling General And Administration | $1,574,117 | $3,435,790 | $1,265,240 | $2,168,217 |
| Reconciled Depreciation | - | $0 | $12,059 | $6,252 |
| Diluted Average Shares | - | $43,891,200 | $187,782,400 | $143,891,200 |
| Basic Average Shares | - | $43,891,200 | $143,891,200 | $143,891,200 |
Fetched: 2026-08-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Total Assets | $30,242,859 | $18,921,784 | $15,811,768 | $13,958,275 |
| Total Non Current Assets | $0 | $387,440 | $62,137 | $15,048 |
| Non Current Deferred Assets | $0 | $387,440 | $42,835 | $0 |
| Current Assets | $30,242,859 | $18,534,344 | $15,749,631 | $13,943,227 |
| Prepaid Assets | $14,684,716 | $5,708,691 | $4,176,695 | $4,916,718 |
| Receivables | $3,656,912 | $1,064,794 | $1,884,960 | $3,581 |
| Other Receivables | $948 | - | - | - |
| Accounts Receivable | $3,655,964 | $1,064,794 | $1,884,960 | $0 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 | $0 |
| Gross Accounts Receivable | $3,655,964 | $1,064,794 | $1,884,960 | $0 |
| Cash Cash Equivalents And Short Term Investments | $11,901,231 | $11,760,859 | $9,687,976 | $8,669,056 |
| Cash And Cash Equivalents | $7,766,738 | $11,760,859 | $9,687,976 | $7,102,271 |
| Non Current Prepaid Assets | - | $0 | $1,293 | $2,989 |
| Non Current Accounts Receivable | - | - | $18,009 | - |
| Inventory | - | - | $0 | $353,872 |
| Taxes Receivable | - | - | $0 | $3,581 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $87,836 | $1,730,234 | $993,060 | $1,411,285 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $87,836 | $1,730,234 | $993,060 | $1,411,285 |
| Payables And Accrued Expenses | $87,836 | $1,730,234 | $993,060 | $1,411,285 |
| Payables | $87,836 | $1,730,234 | $993,060 | $1,411,285 |
| Other Payable | $87,836 | $104,979 | $165,909 | $3,243 |
| Accounts Payable | $0 | $1,625,255 | $827,151 | $1,408,042 |
| Other Current Liabilities | - | - | $-1 | - |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Total Equity Gross Minority Interest | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Stockholders Equity | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Retained Earnings | $23,577,004 | $17,173,541 | $14,800,699 | $12,546,990 |
| Other | ||||
| Ordinary Shares Number | $43,891,200 | $43,891,200 | $43,891,200 | $43,891,200 |
| Share Issued | $43,891,200 | $43,891,200 | $43,891,200 | $43,891,200 |
| Tangible Book Value | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Invested Capital | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Working Capital | $30,155,023 | $16,804,110 | $14,756,571 | $12,531,942 |
| Total Capitalization | $30,155,023 | $17,191,550 | $14,818,708 | $12,546,990 |
| Additional Paid In Capital | $6,563,630 | $3,780 | $3,780 | $0 |
| Capital Stock | $14,389 | $14,229 | $14,229 | $0 |
| Common Stock | $14,389 | $14,229 | $14,229 | $0 |
| Other Short Term Investments | $4,134,493 | $0 | $0 | $1,566,785 |
| Finished Goods | - | - | $0 | $353,872 |
| Current Deferred Revenue | - | - | - | $0 |
| Net PPE | - | - | - | $12,059 |
| Gross PPE | - | - | - | $12,059 |
| Other Properties | - | - | - | $12,059 |
Fetched: 2026-08-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,739,075 | $2,080,387 | $898,367 | $4,448,846 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,739,075 | $2,080,387 | $898,367 | $4,448,846 |
| Cash Flow From Continuing Operating Activities | $-6,739,075 | $2,080,387 | $898,367 | $4,448,846 |
| Operating Gains Losses | $68,003 | $-337,101 | $-163,388 | $-38,885 |
| Investing Activities | ||||
| Investing Cash Flow | $-4,202,496 | $337,101 | $1,730,173 | $-1,527,900 |
| Cash Flow From Continuing Investing Activities | $-4,202,496 | $337,101 | $1,730,173 | $-1,527,900 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,230,000 | $0 | $0 | - |
| Financing Cash Flow | $6,947,450 | $-344,605 | $-42,835 | $0 |
| Cash Flow From Continuing Financing Activities | $6,947,450 | $-344,605 | $-42,835 | $0 |
| Net Other Financing Charges | $-282,550 | $-344,605 | $-42,835 | - |
| Net Common Stock Issuance | $7,230,000 | $0 | $0 | - |
| Common Stock Issuance | $7,230,000 | $0 | $0 | - |
| Other | ||||
| End Cash Position | $7,766,738 | $11,760,859 | $9,687,976 | $7,102,271 |
| Beginning Cash Position | $11,760,859 | $9,687,976 | $7,102,271 | $4,181,325 |
| Changes In Cash | $-3,994,121 | $2,072,883 | $2,585,705 | $2,920,946 |
| Net Investment Purchase And Sale | $-4,202,496 | $337,101 | $1,730,173 | $-1,527,900 |
| Sale Of Investment | $15,217,504 | $35,803,336 | $20,274,423 | $14,561,936 |
| Purchase Of Investment | $-19,420,000 | $-35,466,235 | $-18,544,250 | $-16,089,836 |
| Change In Working Capital | $-13,210,541 | $44,646 | $-1,204,013 | $-5,529,698 |
| Change In Other Current Liabilities | $-17,143 | $-60,930 | $162,666 | $-505,068 |
| Change In Payables And Accrued Expense | $-1,625,255 | $798,104 | $-580,891 | $-481,824 |
| Change In Payable | $-1,625,255 | $798,104 | $-580,891 | $-481,824 |
| Change In Account Payable | $-1,625,255 | $798,104 | $-580,891 | $-481,824 |
| Change In Prepaid Assets | $-8,976,973 | $-1,512,694 | $745,300 | $-4,906,435 |
| Change In Receivables | $-2,591,170 | $820,166 | $-1,884,960 | $717,500 |
| Changes In Account Receivables | $-2,591,170 | $820,166 | $-1,884,960 | $717,500 |
| Gain Loss On Investment Securities | $68,003 | $-337,101 | $-163,388 | $-38,885 |
| Net Income From Continuing Operations | $6,403,463 | $2,372,842 | $2,253,709 | $10,011,177 |
| Change In Inventory | - | $0 | $353,872 | $-353,871 |
| Depreciation Amortization Depletion | - | $0 | $12,059 | $6,252 |
| Depreciation And Amortization | - | $0 | $12,059 | $6,252 |
| Depreciation | - | $0 | $12,059 | $6,252 |
| Other Non Cash Items | - | - | - | $1 |
Fetched: 2026-08-25